These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Incremental prognostic values of serum tenascin-C levels with blood B-type natriuretic peptide testing at discharge in patients with dilated cardiomyopathy and decompensated heart failure. Fujimoto N, Onishi K, Sato A, Terasaki F, Tsukada B, Nozato T, Yamada T, Imanaka-Yoshida K, Yoshida T, Ito M, Hiroe M. J Card Fail; 2009 Dec; 15(10):898-905. PubMed ID: 19944367 [Abstract] [Full Text] [Related]
23. Relation of high concentrations of plasma carboxy-terminal telopeptide of collagen type I with outcome in acute myocardial infarction. Barthélémy O, Beygui F, Vicaut E, Rouanet S, Van Belle E, Baulac C, Degrandsart A, Dallongeville J, Montalescot G, OPERA Investigators. Am J Cardiol; 2009 Oct 01; 104(7):904-9. PubMed ID: 19766754 [Abstract] [Full Text] [Related]
24. Comparison of N-terminal pro-brain natriuretic peptide versus electrophysiologic study for predicting future outcomes in patients with an implantable cardioverter defibrillator after myocardial infarction. Yu H, Oswald H, Gardiwal A, Lissel C, Klein G. Am J Cardiol; 2007 Aug 15; 100(4):635-9. PubMed ID: 17697820 [Abstract] [Full Text] [Related]
26. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction. Steen H, Futterer S, Merten C, Jünger C, Katus HA, Giannitsis E. J Cardiovasc Magn Reson; 2007 Aug 15; 9(5):749-58. PubMed ID: 17891611 [Abstract] [Full Text] [Related]
27. Oxygen-regulated protein 150 and prognosis following myocardial infarction. Ng LL, O'Brien RJ, Quinn PA, Squire IB, Davies JE. Clin Sci (Lond); 2007 Jul 15; 112(9):477-84. PubMed ID: 17176249 [Abstract] [Full Text] [Related]
28. [Brain natriuretic peptide in patients with ST segment elevation myocardial infarction. Prognostic significance]. Dzhaiani NA, Kochetov AG, Kositsyna IV, Golubev AV, Uskach TM, Tereshchenko SN. Ter Arkh; 2006 Jul 15; 78(4):21-6. PubMed ID: 16821416 [Abstract] [Full Text] [Related]
30. B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study. Schnabel R, Lubos E, Rupprecht HJ, Espinola-Klein C, Bickel C, Lackner KJ, Cambien F, Tiret L, Münzel T, Blankenberg S. J Am Coll Cardiol; 2006 Feb 07; 47(3):552-8. PubMed ID: 16458135 [Abstract] [Full Text] [Related]
31. Predictive value of repeated versus single N-terminal pro B-type natriuretic peptide measurements early after-myocardial infarction. Sandhu S, Har BJ, Aggarwal SG, Kavanagh KM, Ramadan D, Exner DV, REFINE Investigators. Pacing Clin Electrophysiol; 2009 Mar 07; 32 Suppl 1():S86-9. PubMed ID: 19250120 [Abstract] [Full Text] [Related]
32. Clinical significance of acute-phase brain natriuretic peptide in acute myocardial infarction treated with direct coronary angioplasty. Katayama T, Nakashima H, Yonekura T, Honda Y, Suzuki S, Yano K. J Cardiol; 2003 Nov 07; 42(5):195-200. PubMed ID: 14658407 [Abstract] [Full Text] [Related]
39. Interleukin-6 and tumor necrosis factor-alpha as biochemical markers of heart failure: a head-to-head clinical comparison with B-type natriuretic peptide. Boffa GM, Zaninotto M, Sartor R, Mion M, Berton A, Pasqualetto C, Razzolini R, Plebani M. J Cardiovasc Med (Hagerstown); 2009 Oct 07; 10(10):758-64. PubMed ID: 19553828 [Abstract] [Full Text] [Related]